Yuan Zhi
Stock Analyst at B. Riley Securities
(0.25)
# 4,063
Out of 4,712 analysts
19
Total ratings
16.67%
Success rate
-31.94%
Average return
Main Sectors:
Stocks Rated by Yuan Zhi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNGX Tango Therapeutics | Maintains: Buy | $16 → $8 | $3.13 | +155.59% | 2 | Nov 11, 2024 | |
| MIR Mirion Technologies | Initiates: Buy | $14 | $16.92 | -17.26% | 1 | Sep 26, 2024 | |
| AGEN Agenus | Maintains: Buy | $42 → $18 | $3.09 | +482.52% | 2 | Aug 14, 2024 | |
| CYRX Cryoport | Upgrades: Buy | $19 → $15 | $7.98 | +87.97% | 4 | Jul 31, 2024 | |
| CTSO Cytosorbents | Reiterates: Buy | $3 | $0.92 | +226.09% | 1 | May 15, 2024 | |
| CATX Perspective Therapeutics | Maintains: Buy | $12 → $17 | $3.31 | +413.60% | 2 | Apr 9, 2024 | |
| AZTA Azenta | Maintains: Buy | $61 → $79 | $50.04 | +57.87% | 3 | Feb 1, 2024 | |
| ATNM Actinium Pharmaceuticals | Maintains: Buy | $20 → $16 | $1.26 | +1,169.84% | 4 | Dec 11, 2023 |
Tango Therapeutics
Nov 11, 2024
Maintains: Buy
Price Target: $16 → $8
Current: $3.13
Upside: +155.59%
Mirion Technologies
Sep 26, 2024
Initiates: Buy
Price Target: $14
Current: $16.92
Upside: -17.26%
Agenus
Aug 14, 2024
Maintains: Buy
Price Target: $42 → $18
Current: $3.09
Upside: +482.52%
Cryoport
Jul 31, 2024
Upgrades: Buy
Price Target: $19 → $15
Current: $7.98
Upside: +87.97%
Cytosorbents
May 15, 2024
Reiterates: Buy
Price Target: $3
Current: $0.92
Upside: +226.09%
Perspective Therapeutics
Apr 9, 2024
Maintains: Buy
Price Target: $12 → $17
Current: $3.31
Upside: +413.60%
Azenta
Feb 1, 2024
Maintains: Buy
Price Target: $61 → $79
Current: $50.04
Upside: +57.87%
Actinium Pharmaceuticals
Dec 11, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $1.26
Upside: +1,169.84%